Evidence map›Paper›PMID 42795896›Full record

ArticleJournal of clinical medicine2026

Herpesviridae Reactivation and Therapeutic Outcomes in Patients with Ulcerative Colitis Treated with Tofacitinib.

Sivan Harnik, Naama Lang, Shiran Yehezkel, Ella Fudim, Miri Yavzori, Orit Piccard, Orel Finkel, Tal Meningher, Or Lya Abayev, Michal Tepperberg Oikawa and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sivan HarnikDepartment of Gastroenterology, Sheba Medical Center Tel Hashomer, Ramat Gan 5265601, Israel.ORCID 0000-0001-6939-2688
Naama LangDepartment of Gastroenterology, Sheba Medical Center Tel Hashomer, Ramat Gan 5265601, Israel.
Shiran YehezkelDepartment of Gastroenterology, Sheba Medical Center Tel Hashomer, Ramat Gan 5265601, Israel.
Ella FudimDepartment of Gastroenterology, Sheba Medical Center Tel Hashomer, Ramat Gan 5265601, Israel.
Miri YavzoriDepartment of Gastroenterology, Sheba Medical Center Tel Hashomer, Ramat Gan 5265601, Israel.
Orit PiccardDepartment of Gastroenterology, Sheba Medical Center Tel Hashomer, Ramat Gan 5265601, Israel.
Orel FinkelDepartment of Gastroenterology, Sheba Medical Center Tel Hashomer, Ramat Gan 5265601, Israel.
Tal MeningherDepartment of Gastroenterology, Sheba Medical Center Tel Hashomer, Ramat Gan 5265601, Israel.
Or Lya AbayevDepartment of Gastroenterology, Sheba Medical Center Tel Hashomer, Ramat Gan 5265601, Israel.
Michal Tepperberg OikawaCentral Virology Laboratory, Sheba Medical Center, Ministry of Health, Ramat Gan 5265601, Israel.
Sara DovratCentral Virology Laboratory, Sheba Medical Center, Ministry of Health, Ramat Gan 5265601, Israel.
Rachel SihraziCentral Virology Laboratory, Sheba Medical Center, Ministry of Health, Ramat Gan 5265601, Israel.
Shomron Ben-HorinDepartment of Gastroenterology, Sheba Medical Center Tel Hashomer, Ramat Gan 5265601, Israel.
Bella UngarDepartment of Gastroenterology, Sheba Medical Center Tel Hashomer, Ramat Gan 5265601, Israel.

Funding

Pfizer (United States) 64184455
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

fecal calprotectinHerpesviridaeHSVJanus kinase inhibitorsalivary PCRtofacitinibulcerative colitisviral reactivationVZV

Identifiers

PMID42795896
PMCPMC13607807

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.